ARUK 2018 | Progress in developing novel drugs for the treatment of dementia

There are many different approaches that can be taken to the treatment of dementia, with centers across the UK carrying out essential research in these areas. Speaking from the Alzheimer’s Research UK (ARUK) Conference 2018, held in London, UK, John Skidmore, BA, DPhil, of the ARUK Cambridge Drug Discovery Institute, Cambridge, UK, discusses the progress being made in developing a treatment for dementia, moving from a focus on amyloid, to targeting other processes and proteins, such as tau. Dr Skidmore highlights the work of the ambitious ARUK Drug Discovery Alliance, made up of three Drug Discovery Institutes in Cambridge, Oxford and University College London, and his predictions of what the future of dementia treatment may look like.